Compare Exelixis Inc. Common Stock (EXEL) vs FMC Corp (FMC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Exelixis Inc. Common Stock vs FMC Corp — how do they compare? Exelixis Inc. Common Stock trades at $59.86 (market cap $14.62B), while FMC Corp trades at $8.35 (market cap $1.39B). The key difference: Exelixis Inc. Common Stock is far larger — about 10.5× FMC Corp's market cap, and FMC Corp pays a 3.59% dividend while Exelixis Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Exelixis Inc. Common Stock for 1 Days and FMC Corp for 68 Days on average.
| EXEL | FMC | |
|---|---|---|
Market Cap | $14.62B | $1.39B |
Volume | 2,684,957 | 4,145,979 |
Sector | Health | Basic Materials |
52-Week High | $59.13 | $30.63 |
52-Week Low | $34.54 | $8.44 |
Typical Hold Time | 1 Days | 68 Days |
Enterprise Value | $13.95B | $5.19B |
Dividend Yield | — | 3.59% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
FMC stock trades at $8.35, down 8.14% on the day, reflecting bearish technical signals and weak profitability. Despite a low P/S ratio of 0.34 and recent earnings beats, the company reported a net income margin of -84.83% in 2025. Recent news includes a regulatory filing in Brazil for a new herbicide and a minority equity investment by Tessenderlo Group.
The outlook remains challenging due to high debt and cyclical headwinds, though management's deleveraging efforts and a consensus price target of $14.60 suggest potential upside. Key risks include persistent negative margins, volatile cash flows, and industry pressures.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Exelixis Inc. Common Stock
Exelixis develops and commercializes medicines for cancer. Its research focuses on targeted therapies for oncology.
Read more on EXEL →About FMC Corp
FMC is a pure-play crop chemical company. The company has diversified its sales to create a balanced crop chemical portfolio across geographies and crop exposure. Through acquisitions, FMC is now one of the five largest patented crop chemical companies and will continue to develop new products, with a focus on biologicals, through its research and development pipeline.
Read more on FMC →
